Table 4.
Unadjusted probability of outcomes by donor type and age group at 5-years after HCT for the most recent cohort (2002–2007)
Outcome | Matched Sibling Donor | Unrelated Donor |
---|---|---|
Probability (95% CI) | Probability (95% CI) | |
Overall survival | ||
Children | 68 (56–81) | 56 (50–62) |
AYAs | 48 (38–59) | 42 (37–47) |
Older adults | 33 (24–46) | 37 (30–44) |
Leukemia-free survival | ||
Children | 61 (49–75) | 52 (46–58) |
AYAs | 34 (34–54) | 38 (33–43) |
Older adults | 31 (23–43) | 34 (28–41) |
Relapse | ||
Children | 34 (21–47) | 27 (22–32) |
AYAs | 31 (22–41) | 31 (26–35) |
Older adults | 29 (19–40) | 24 (18–30) |
Treatment-related mortality | ||
Children | 5 (1–13) | 21 (16–26) |
AYAs | 25 (17–35) | 32 (27–37) |
Older adults | 39 (28–50) | 42 (34–49) |
Abbreviations: AYAs – Adolescent and young adults; CI – confidence intervals